Prime Medicine (PRME) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free PRME Stock Alerts $4.70 -0.10 (-2.08%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePrime Medicine's (PRME) Outperform Rating Reaffirmed at Wedbushamericanbankingnews.com - April 24 at 5:20 AMPrime Medicine's (PRME) "Outperform" Rating Reiterated at Wedbushmarketbeat.com - April 23 at 1:47 PMPrime Medicine (NYSE:PRME) Shares Up 8.8%marketbeat.com - April 23 at 1:23 PMPrime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetingsglobenewswire.com - April 23 at 8:00 AMPrime Medicine (NYSE:PRME) Now Covered by Chardan Capitalamericanbankingnews.com - April 23 at 4:20 AMBuy Rating Affirmed for Prime Medicine, Inc. on Groundbreaking Genetic Editing Platform and Strategic Progressmarkets.businessinsider.com - April 23 at 12:41 AMChardan Capital Initiates Coverage of Prime Medicine (PRME) with Buy Recommendationnasdaq.com - April 22 at 7:41 PMPrime Medicine (NYSE:PRME) Shares Gap Up to $4.51marketbeat.com - April 22 at 12:49 PMPrime Medicine (NYSE:PRME) Research Coverage Started at Chardan Capitalmarketbeat.com - April 22 at 8:22 AMPrime Medicine (NYSE:PRME) Stock Price Down 5.7%marketbeat.com - April 18 at 4:55 PMPrime Medicine (NYSE:PRME) Sets New 12-Month Low at $5.46marketbeat.com - April 15 at 2:49 PMPrime Medicine (NYSE:PRME) Trading Down 4.1%marketbeat.com - April 11 at 1:48 PMPrime Medicine, Inc. (NYSE:PRME) Stock Position Boosted by Vanguard Group Inc.marketbeat.com - April 11 at 4:11 AMTD Cowen initiates Prime Medicine stock with Buy on editing platformuk.investing.com - April 10 at 1:43 AMPrime Medicine (NYSE:PRME) Stock Price Up 5.4%marketbeat.com - April 8 at 2:30 PMPrime Medicine (NYSE:PRME) Now Covered by Analysts at TD Cowenmarketbeat.com - April 8 at 8:19 AMPrime Medicine (NYSE:PRME) Sets New 52-Week Low at $5.48marketbeat.com - April 5 at 12:21 PMPrime Medicine, Inc. to Post Q1 2024 Earnings of ($0.45) Per Share, Wedbush Forecasts (NYSE:PRME)marketbeat.com - April 5 at 8:06 AMPrime Medicine, Inc. (NYSE:PRME) Given Average Rating of "Moderate Buy" by Brokeragesmarketbeat.com - April 5 at 6:36 AMPrime Medicine (NYSE:PRME) Trading Down 8.1%marketbeat.com - April 2 at 5:45 PMPrime Medicine (NYSE:PRME) Earns Outperform Rating from Analysts at Wedbushmarketbeat.com - April 2 at 4:35 PMARK Investment Management LLC Has $27.81 Million Stock Holdings in Prime Medicine, Inc. (NYSE:PRME)marketbeat.com - March 28 at 6:39 AM2 Magnificent Growth Stocks With Room to Runfool.com - March 27 at 8:45 AMPrime Medicine (NYSE:PRME) Shares Gap Up to $6.87marketbeat.com - March 26 at 12:26 PMPrime Medicine (NYSE:PRME) Shares Down 6% marketbeat.com - March 18 at 11:55 AM13 Best Little-Known Perks You Can Get From Amazon Primecnet.com - March 15 at 7:42 PMGeron wins FDA AdCom backing for blood cancer drugmsn.com - March 14 at 6:12 PMShort-Squeeze Roulette: 3 Stocks That Could Leave Bears Begginginvestorplace.com - March 14 at 2:44 PMBuy Rating Justified: Prime Medicine’s Promising Clinical Prospects and Innovative Gene Editing Technology Poised for Growthmarkets.businessinsider.com - March 12 at 6:16 PMPrime Medicine (NYSE:PRME) Shares Down 3.9% marketbeat.com - March 12 at 1:24 PMBlinken to travel to Jamaica for CARICOM meeting on Haiti, US State Dept saysmsn.com - March 12 at 1:16 PMPrime Medicine, Inc. (NYSE:PRME) Receives Consensus Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - March 11 at 6:17 AMPrime Medicine (NYSE:PRME) Stock Price Down 6.6% on Analyst Downgrademarketbeat.com - March 5 at 3:18 PMPrime Medicine (NYSE:PRME) PT Lowered to $20.00 at Guggenheimmarketbeat.com - March 5 at 1:13 PMBuy Rating Affirmed for Prime Medicine, Inc. on Anticipated IND Filing and Strong Gene Editing Pipelinemarkets.businessinsider.com - March 4 at 5:05 PMFmr LLC Sells 116,803 Shares of Prime Medicine, Inc. (NYSE:PRME)marketbeat.com - March 3 at 5:14 AMCathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?investorplace.com - March 1 at 2:00 PMRecap: Prime Medicine Q4 Earningsbenzinga.com - March 1 at 1:49 PMPrime Medicine GAAP EPS of -$2.18msn.com - March 1 at 1:49 PMPrime Medicine Reports Full Year 2023 Financial Results and Provides Business Updatesglobenewswire.com - March 1 at 8:00 AMThomas Cahill's Net Worthbenzinga.com - February 29 at 8:05 PMPrime Medicine to Participate in Upcoming Investor Conferencesglobenewswire.com - February 28 at 8:00 AMStock Offerings Prompt Big Insider Buying247wallst.com - February 27 at 8:45 AM128,876 Shares in Prime Medicine, Inc. (NYSE:PRME) Acquired by Rafferty Asset Management LLCmarketbeat.com - February 24 at 5:34 AMPRME Mar 2024 12.500 callfinance.yahoo.com - February 23 at 8:16 AMPrime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Sharesglobenewswire.com - February 20 at 4:01 PMPrime Medicine (NYSE:PRME) Trading Up 5.5%marketbeat.com - February 16 at 11:54 AMPrime Medicine, Inc.: Prime Medicine Announces Pricing of Upsized Public Offeringfinanznachrichten.de - February 15 at 1:34 PMPrime Medicine down 5%, prices $140M stock offeringmsn.com - February 15 at 8:33 AMPrime Medicine Announces Pricing of Upsized Public Offeringfinance.yahoo.com - February 15 at 1:15 AM Get Prime Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for PRME and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here PRME Media Mentions By Week PRME Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRME News Sentiment▼0.320.43▲Average Medical News Sentiment PRME News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRME Articles This Week▼122▲PRME Articles Average Week Get Prime Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for PRME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HilleVax News Allogene Therapeutics News Valneva News Mesoblast News Novavax News Fate Therapeutics News Alector News Cabaletta Bio News CARGO Therapeutics News Taysha Gene Therapies News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PRME) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe Greatest Bull Market in Crypto History…Weiss RatingsNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
